Summary
- Current Price
- As of today, RDHL price is $1.00, up +1.50% on
- Current Price All-Time High
- RDHL price is currently -100.00% below its historical high of $22,220.00 set on
- Market Cap
- RDHL current market cap is $5M, down -26.55% year-over-year
- PE Ratio
- RDHL PE ratio is unknown
- Revenue
- RDHL current annual revenue is $8.08M, up +24.07% year-over-year
- Next Earnings
- As of today, the next earnings release for RDHL has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | RedHill Biopharma Ltd. |
| Ticker | NASDAQ: RDHL |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | Israel |
| IPO | |
| Indexes | Not included |
| Website | redhillbio.com |
| Employees | 35 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.00 | ||
| Price, 1D Change | +1.50% | |
| $5M | ||
| - | ||
| - | ||
| 1.27 | ||
| $8M | ||
| Revenue, 1Y Change | +24.07% | |
| -$6.73 | ||
| EPS, 1Y Change | -107.31% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:25 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$6.73 | ||
| EPS Estimate | N/A | - |
| EPS Est. Change | N/A | - |
| $8.08M | ||
| Revenue Estimate | N/A | $38.00M |
| Revenue Est. Change | N/A | +370.23% |
| $1.00 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | N/A | - | |
| - | $92.06 | - | |
| - | -$6.73 | - | |
| - | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.00 | N/A | - | |
| - | $6.51M | - | |
| $20.80M | $8.08M | -61.15% | |
| $38.00M | N/A | +370.23% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -81.34% | ||
| -99.52% | ||
| -26.55% | ||
| -73.88% | ||
| +24.07% | ||
| -90.58% | ||
| -107.31% | ||
| +99.68% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $1.00 | ||
| $1.53 | ||
| SMA 200 vs Price | +53.37% | |
| $1.19 | ||
| SMA 50 vs Price | +18.98% | |
| 1.27 | ||
| $0.09 | ||
| 36.30 | ||
| 55.43% | ||
| 103.89% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $8.08M | ||
| -$6.73 | ||
| $4.87M | ||
| 60.31% | ||
| -$12.31M | ||
| -152.36% | ||
| -$8.31M | ||
| -102.80% | ||
| -$11.69M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -0.08 | ||
| 0.54 | ||
| 0.37 | ||
| - | ||
| - | ||
| -34.54 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| -0.51 | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$4.68M | ||
| $4.62M | ||
| $18.04M | ||
| $11.91M | ||
| $22.73M | ||
| $22.22M | ||
| $356.00K | ||
| $353.00K | ||
| $1.17M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $16.39M | ||
| $17.19M | ||
| $3.21M | ||
| $0.00 | ||
| $621.90K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$9.41M | ||
| -$9,000.00 | ||
| $8.46M | ||
| $9,000.00 | ||
| -$9.42M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | ||
| Cantor Fitzgerald | ||
| WBB Securities | → | |
| HC Wainwright & Co. | ||
| BTIG | ||
| H.C. Wainwright | ||
| WBB Securities | → | |
| WBB Securities | → | |
| Ladenburg Thalmann | ||
| Nomura |
Analyst sentiment
Institutional ownership
Screeners with RDHL
FAQ
What is the ticker symbol for RedHill Biopharma Ltd.?
The ticker symbol for RedHill Biopharma Ltd. is NASDAQ:RDHL
Does RedHill Biopharma Ltd. pay dividends?
No, RedHill Biopharma Ltd. does not pay dividends
What sector is RedHill Biopharma Ltd. in?
RedHill Biopharma Ltd. is in the Healthcare sector
What industry is RedHill Biopharma Ltd. in?
RedHill Biopharma Ltd. is in the Specialty & Generic Drug Manufacturers industry
What country is RedHill Biopharma Ltd. based in?
RedHill Biopharma Ltd. is headquartered in Israel
When did RedHill Biopharma Ltd. go public?
RedHill Biopharma Ltd. initial public offering (IPO) was on January 7, 2013
Is RedHill Biopharma Ltd. in the S&P 500?
No, RedHill Biopharma Ltd. is not included in the S&P 500 index
Is RedHill Biopharma Ltd. in the NASDAQ 100?
No, RedHill Biopharma Ltd. is not included in the NASDAQ 100 index
Is RedHill Biopharma Ltd. in the Dow Jones?
No, RedHill Biopharma Ltd. is not included in the Dow Jones index
When was RedHill Biopharma Ltd. last earnings report?
RedHill Biopharma Ltd.'s most recent earnings report was on April 25, 2017
When does RedHill Biopharma Ltd. report earnings?
The date for RedHill Biopharma Ltd.'s next earnings report has not been announced yet
Data Sources & References
- RDHL Official Website www.redhillbio.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1553846/000155837025004648/0001558370-25-004648-index.htm
- RDHL Profile on Yahoo Finance finance.yahoo.com/quote/RDHL
- RDHL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rdhl